Background Quantitative computed tomography (CT) assessment of visceral adiposity may be superior to body mass index (BMI) as a predictor of surgical morbidity. We sought to examine the association of CT measures of obesity and BMI with shortterm postoperative outcomes in colon cancer patients. . Postoperative morbidity and mortality rates were compared. Results Obese patients, by V/S and VFA but not BMI, were more likely to be male and have preexisting hypertension and diabetes. The overall complication rate was 25.5%, and there were no mortalities. Obese patients by VFA (with a trend for V/S but not BMI) were more likely to develop postoperative complications as compared to patients classified as non-obese: VFA (30.5 vs.10.7%, p = 0.03), V/S (29.2 vs. 9.5%, p = 0.05), and BMI (32.4 vs. 21.9%, p = 0.23). Conclusions Elevated visceral obesity quantified by CT is associated with the presence of key metabolic comorbidities and increased postoperative morbidity and may be superior to BMI for risk stratification.
Introduction
Obesity in the USA has reached epidemic proportions, with an estimated 66% of the population being classified as overweight and/or obese. 1 Obesity is thought to play a contributing role in the development and prognosis of a number of cancers.
2 , 3 In particular, colorectal cancer accounts for approximately 51,900 annual deaths in the USA, 5 and obesity has been associated with more than 20% of colorectal cancerrelated deaths. 4 In addition to being a potential contributor to colorectal cancer development, it has also been suggested that obesity may also influence short-term surgical outcomes. Body mass index (BMI) has been the conventional tool used to derive body weight categories and for calculating chemotherapy dosage. However, the association between BMI as a measure of obesity and adverse surgical outcomes in colorectal cancer Oluwatobi O. Ozoya and Erin M. Siegel contributed equally to this work.
Electronic supplementary material
The online version of this article (doi:10.1007/s11605-017-3362-9) contains supplementary material, which is available to authorized users. remains inconsistent. 6 , 7 These conflicting data may be attributable, in part, to the lack of accurate estimation of body fat distribution by BMI measurement.
Adipose tissue distribution in the body is diverse, and different fat depots have different metabolic activity. Visceral fat compared to subcutaneous fat tissue appears to enhance adverse metabolic outcomes.
8
, 9 Besides metabolic syndrome, excess visceral fat is thought to predispose to chronic inflammation and release of growth factors that could mediate colonic neoplasia.
10
, 11 Due to these biological differences, it is important to differentiate visceral or intra-abdominal fat from other fat depots. Conventional methods attempting to estimate intra-abdominal fat include waist circumference and waist-tohip ratio 12 , 13 ; however, these measures lack the accuracy to clearly distinguish subcutaneous from visceral abdominal fat.
6 , 14 , 15 Recent studies have leveraged computed tomography (CT) imaging to differentiate and quantify visceral and subcutaneous adiposity. Visceral obesity has been reported as visceral fat area (VFA) 17 greater than 100 cm or a visceral fat/ subcutaneous fat area (V/S ratio) 18 above 0.4. These quantitative measures of visceral obesity have been shown to be associated with the metabolic syndrome. 19 In the background of an epidemic of obesity and its high prevalence among colorectal cancer surgical patients, it is critical to understand the impact of adiposity, and more accurately the distribution of adipose tissue, on both short-and long-term surgical outcomes. More precise distinction of fat distribution may improve prognostication of outcomes of surgery among colon cancer patients. There is a limited but growing literature supporting the association between radiologically defined measures of visceral adiposity and both short-and long-term colorectal cancer outcomes.
6 , 16 In brief, significant associations have been described between visceral adiposity and rectal cancer treatment outcomes.
6 , 16 Among a small and heterogeneous population of colon cancer patients, visceral obesity (e.g., VFA of >100 cm 2 or V/S > 0.4) was associated with poor surgical outcomes.
6 , 17 Moreover, diagnostic CT adiposity measurements before colon cancer surgery among a generally heterogeneous patient population were reported to be significantly associated with short-term complications such as wound complication, venous thrombosis, and incisional hernia, whereas BMI was not. 20 , 21 While suggestive, these retrospective studies have limitations and fraught with heterogeneity (e.g., inclusion of benign and malignant disease, colon and rectal cancers, and differing endpoints), which limit conclusions with respect to specific conditions. Moreover, there are certainly a number of complications (e.g., thromboembolic disease) that may be more common in cancer patients, and as such, it is certainly justifiable to study such patients as a separate group.
In the current study, we sought to examine the association between pretreatment CT measures of visceral adiposity with the prevalence of metabolic comorbidities and short-term surgical outcomes in a relatively homogeneous group of stage I-III colon cancer patients. We hypothesize that radiologic measures of obesity would be superior to BMI in predicting short-term surgical outcomes among colon cancer patients.
Materials and Methods
This research is part of a larger prospective cohort of 437 colon and rectal cancer patients evaluating factors associated with short-and long-term patient outcomes. The total population of 437 had more males (58%) compared with females (42%), and both had a mean age of 64 years. The disease distribution in the total population was 53.7% (235) of patients diagnosed with cancer in the colon and rectosigmoid junction, 44.6% (195) rectal cancer, and 1.6% (7) had stage 0 disease (in situ or no evidence of disease). All patients provided informed consent.
Patient Selection and Chart Review
For this IRB-approved study, a cohort of 110 patients who had surgery for stage I-III colon cancer performed at the Moffitt Cancer Center between 2006 and 2015 with available preoperative routine staging CT scans were identified. Rectosigmoid cancers (n = 11) were included if they were anatomically proximal and treated as a colon cancer (e.g., surgery followed by adjuvant therapy if indicated). Patients were excluded if they received neoadjuvant therapy. Data were abstracted on patient demographics, preoperative comorbidities, TNM stage, histological grade, and any complications within 30 days following surgery. Medical records were reviewed and abstracted on standardized abstraction forms. Abstracted data were logged into a secure Microsoft Access database.
Short-Term Post-surgery Morbidity
The nature of the complications included was either surgical or medical during the first 30 days following resection. Specific morbidities were recorded as documented in medical records. In addition, the Clavien-Dindo surgical complication grading system was utilized to further classify documented outcomes prior to statistical analysis. 22 The Clavien-Dindo scale includes: grade 1 (deviation from normal postoperative course without the need for pharmacological, surgical endoscopic, or radiological interventions); grade II (requiring pharmacological, blood transfusion, and total parenteral nutrition); grade III (requiring surgical, endoscopic, or radiological intervention); grade IV (lifethreatening complications requiring intensive care unit management); and grade V (death of a patient). Patients who had more than one complication were classified using the highest grade of reported complication.
, 23

Adiposity Measurement
Patients included in the study had availability of an archived preoperative digitized CT scan (n = 110). Radiologic measurement was performed on diagnostic CT scans using a GE AW digital workstation (General Electric Healthcare) by radiologist-trained personnel who were blinded to patient data and outcomes. As previously reported, 16 adipose tissue was segmented by setting the CT attenuation level between −190 and −30 Hounsfield units with subsequent delineation of visceral and subcutaneous regions. Visceral and subcutaneous fat areas were quantified using CT axial slices taken at the L4-L5 intervertebral span.
16 , 24 , 25 The VFA-to-subcutaneous fat area (SFA) ratio (V/S) was computed as a parameter for visceral adiposity as previously described. 16 The threshold for elevated V/S was set at 0. The error rate was set at 0.5% as previously described.
25 , 27 BMI was calculated for each subject from the height and weight in standard fashion.
Statistical Analysis
BMI and V/S-determined adiposity were analyzed as continuous measures or categorized using a predetermined cut point (BMI ≥ 30 kg/m 2 , V/S ≥ 0.4, and VFA ≥ 100 cm 2 ). As appropriate, chi-square or Fischer's exact tests (categorical) or twosample t test with equal or unequal variance (continuous) were used to determine differences in adiposity based on clinical, pathological, and perioperative features. Short-term surgical outcomes were examined according to frequency and severity. The Clavien-Dindo scale, which assesses severity of surgical complications, was dichotomized into two groups: minor (grades 1 and 2) vs. major (grades 3 and 4) for comparisons. All statistical tests were two-sided and deemed statistically significant at the level of 0.05, unless otherwise specified. Analyses were performed using SPSS (IBM SPSS Statistics 22).
Results
Demographics and Clinical Features
The study population consisted of 110 patients with stage I-III colon cancer, with a mean age of 66 ± 12 years (Table 1) . There were slightly more male patients than females (n = 60 vs. n = 50), and almost all patients were white (94%). The frequencies of hypertension, diabetes, and hypercholesterolemia in this population were 50.9, 11.8, and 31.8%, respectively.
The majority of cases were performed laparoscopically (66%), while open (33%) and hybrid (1%) accounted for other approaches. Thirty-four percent of patients had a BMI ≥30 kg/ m 2 , while 81% of patients were classified as obese by V/S (≥0.4) and 75% by VFA (>100 cm 2 ).
Body Mass Index and Visceral Obesity by Sex
A complete description of BMI and visceral adiposity variables stratified by gender is presented in Table 2 . The overall mean BMI of these colon cancer patients was 28. 
Adiposity Measures by Preoperative Characteristics
A summary of selected preoperative variables as a function of BMI, V/S, and VFA is presented in Table 3 . With respect to mean BMI, colon cancer patients with hypertension, diabetes, and hypercholesterolemia did not differ from those without these conditions (p = 0.15, p = 0.67, and p = 0.74, respectively). Pathological stage, complications, or grade of complication were not associated with significant differences in mean BMI (p = 0.40, p = 0.16, and p = 0.37). In contrast to BMI, colon cancer patients with V/S ≥ 0.4 were significantly more likely to be male (61.8 vs. 23.8%, p = 0.002) and have preexisting hypertension (56.2 vs. 28.6%, p = 0.02) compared to those with V/S < 0.4. Patients with V/S ≥ 0.4 had a marginally significant likelihood of having preexisting diabetes. Similar findings were observed when V/S was considered as a continuous measure, with mean V/S ratio significantly higher in patients with preexisting hypertension (0.76 ± 0.39 vs. 0.57 ± 0.37, p = 0.01) and diabetes (0.95 ± 0.51 vs. 0.63 ± 0.35, p = 0.004) compared to patients who did not have those preexisting conditions. When visceral obesity was defined by VFA alone, colon cancer patients with VFA ≥ 100 cm 2 were significantly more likely to be male (61 vs. 39%, p = 0.02) and have preexisting hypertension (63 vs. 37%, p < 0.001) and diabetes (16 vs. 84%, p = 0.04) compared to those with VFA < 100 cm 2 . Similar results were observed when VFA was evaluated as a continuous variable.
Adiposity Measures by Postoperative Outcomes
The overall complication rate was 25.5% (28/110), with no mortality (Supplemental Table 1 ). Short-term complications included wound infection (in eight), seroma (five), anastomotic leaks (four), arrhythmia (three), ileus/small bowel obstruction (two), thromboembolism (two), wound hematoma (two), wound dehiscence (one), and urinary retention (one). The association between postoperative variables and adiposity measures is presented in Table 4 
Discussion
The impact of BMI on surgical outcomes in colon cancer patients has remained somewhat controversial. This uncertainty may be related to the fact that BMI does not account for the specific distribution of body fat. In the current study, BMI was not associated with the presence of key comorbid factors and was not predictive of postoperative morbidity. On the other hand, we observed that radiologically determined visceral obesity (V/S and VFA) was associated with the presence of key preoperative metabolic comorbidities in colon cancer patients. Furthermore, virtually all patients who experienced postoperative complications were classified as obese by CT measures, but not necessarily by BMI. While we did observe an increased frequency of short-term postoperative complications among viscerally obese patients, we were unable to detect an association with severity of complications as defined by the Clavien-Dindo grading system. This lack of an association may have been due to the small number of severe Differences in adiposity by short-term outcomes were determined by one-way ANOVA or chi-square Fisher's exact test, as appropriate BMI body mass index, VFA visceral fat area, SFA subcutaneous fat area, V/S visceral fat to subcutaneous fat ratio complications within the study population (e.g., only 2 grade III and 3 grade IVout of 110 patients, all of which occurred in viscerally obese patients).
Our findings regarding the association between visceral obesity and preoperative metabolic comorbidities are consistent with previous studies that have linked cardiovascular risk factors to increased visceral fat. 19 Hiuge-Shimizu et al. have reported that VFA and SFA were associated with obesityrelated diabetes and hypertension, whereas BMI was not.
18
, 19 In addition, VFA ≥ 100 cm 2 has been shown to be associated with obesity-related cardiovascular risk factors 25 and increased odds of developing coronary artery disease. 28 In our study, the proportions of men and women who were obese by BMI were equivalent; however, by radiologic measures, men were substantially more likely to be viscerally obese than women. Similar observations were noted by Cakir et al., showing that men were frequently more viscerally obese by radiologic classification. 15 Such gender-related observations are similar to those reported by Healy et al., in which they noted no significant differences in major morbidity using BMI-classified obesity. 29 Our findings suggest that radiologic measures of visceral obesity may be superior to BMI in gender-based preoperative risk stratification.
We have observed that visceral obesity as defined by V/S and VFA was significantly associated with a higher rate of postoperative complications among colon cancer patients. Our findings provide additional supportive evidence to the emerging literature in this area, which, however, has included very heterogeneous patient populations. Our study controlled for type of surgery, yet the VFA was still predictive. 17 In a study of both colon and rectal cancer surgery cases, Aquina et al. demonstrated that visceral obesity as defined by VFA was predictive of higher risk of incisional hernia. 20 This finding is supported by Watanabe et al., who showed that, among a cohort of 338 colon cancer patients, visceral obesity (defined by VFA) is superior to BMI in predicting overall short-term complications following laparoscopic surgery. 17 Our study further demonstrates that VFA is still predictive of shortterm outcome regardless of surgical approach. Our findings also support a study of a similar cohort of Dutch patients in which visceral obesity as defined by VFA was predictive of a higher risk of anastomotic leaks and surgical site infections. 15 In one dissenting study, Cecchini et al. were unable to demonstrate an association of visceral adiposity with overall shortterm complications in patients undergoing colon surgery for both benign and malignant processes. 21 The precise biological mechanisms that underlie the association between obesity and colon cancer surgery outcomes remain under investigation. A number of factors such as impaired inflammatory response, microvascular dysfunction, 30 , 31 and poor tissue oxygen tension (skin, wound, and adipose) 32 are implicated. Despite antibiotic prophylaxis, subtherapeutic tissue antibiotic concentrations are observed in obese patients and may result in less impact on preventing wound infection in such individuals. 33 , 34 In addition, the development of wound infection may be enhanced by an attenuated inflammatory response secondary to endotoxin tolerance in obese patients.
35
, 36 A stronger understanding of the contribution of obesity to surgical site infection would be valuable given its association with subsequent risk of systemic infection and worse long-term outcomes. 3 Seroma formation in colon cancer surgery is less studied compared to breast surgery, but has been linked to obesity, wound dead space, technique, and comorbidity, among other factors.
37
, 38 In addition, seroma has been linked with increased risk of postoperative wound infection, hematoma formation, cancer recurrence, and poor long-term survival.
39 , 40 Anastomotic leaks have been associated with risk factors such as smoking, distal rectal cancers, and obesity (BMI > 25 kg/m 2 ).
, 41
The observed poor outcomes among viscerally obese patients may, in part, be attributable to the technical challenges arising from excess intra-abdominal fat encountered during operation.
16 , 23 Of note is that, in this study, surgical approach (open vs. laparoscopic) was not a predictor of increased complications among visceral obesity groups whether categorized by BMI, V/S, or VFA as compared to non-obese counterparts (Supplemental Table 2 ). Moreover, the proportion of laparoscopic cases was fairly equal between obese and non-obese groups across BMI, V/S, and VFA (Supplemental Table 2 ). As such, differences in the rates of postoperative morbidity are not explained by surgical approach.
A limitation of this study is its observational nature and inherent accompanying biases. Certainly, CT measurement of visceral fat is operator-dependent and more time-consuming than BMI measurement, yet with respect to ultimate applicability in clinical practice, radiologic segmentation software has made it increasingly possible for these measures to be performed in automated fashion off of available digital clinical radiology platforms. Moreover, given that all these measurements are performed on standard of care preoperative colon cancer staging CT scans, it is unusual to not have such scans prior to operation on such patients.
Another inherent limitation is the relatively small sample size, which restricted analytic power and did not allow complication types to be individually examined for significance. It could also be argued that our findings may not be generalizable as the study population represents a sample of predominantly white patients from a single center. Conducting similar studies among different racial and ethnic groups is indicated to further validate our observations. Nonetheless, our sample population was fairly homogeneous with restriction to stage I to III colon cancer patients. This further reduced variances in outcomes that may have been due to the stage or treatment and removed the influence of the impact of metastatic disease (i.e., stage IV) and/or cachexia on body fat composition. We also ensured that CT measurement was performed on pretreatment scans closest to surgery to ensure a more accurate reflection of visceral adipose tissue at time of surgery.
Notably, our observation that visceral obesity (rather than BMI) was associated with preexisting metabolic abnormalities provides further evidence for its biological relevance. Although our study has focused on short-term outcomes, further examination of the impact of visceral adiposity status on long-term outcomes is warranted. It is conceivable that accurately quantified visceral obesity may serve as a predictor of both short-and long-term outcomes in patients with surgically resected stage I-III colon cancer. Future clinical utility of the concept of radiologically defined visceral obesity would be enhanced by integration as a correlative measure in clinical trials and also facilitated by the continued development of automated image segmentation techniques.
Conclusion
The obesity epidemic in this country may have a significant impact on surgical outcomes among colon cancer patients. The traditionally used measure of BMI may be limited by its lack of quantification of visceral fat distribution. We have demonstrated that excess CTmeasured visceral adiposity is associated with the presence of key metabolic comorbidities and an increased rate of short-term postoperative complications following colon cancer resection. Larger studies are warranted to further determine the role of radiologic visceral fat assessment for preoperative risk stratification in colon cancer patients.
